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Phospholipase A2 (PLA2)4 enzymes catalyze the cleavage of
the sn-2-ester bond of phospholipids to yield free fatty acids,
such as arachidonic acid, and lysophospholipids (1–3). Both
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products represent precursors for signaling molecules that can
exert multiple biological functions. Calcium-independent
PLA2s (iPLA2s) are members of the group VI family of PLA2
enzymes (3, 4). Group VIB (iPLA2␥) is homologous to iPLA2␤
in the C-terminal catalytic domain but shows no similarities in
the N-terminal region; accordingly, iPLA2␥ has regulatory
properties distinct from those of iPLA2␤ (3, 5, 6).
Genetic ablation of iPLA2␥ in mice resulted in the generation
of viable progeny that demonstrated reduced growth rate as
well as cold intolerance due to impaired fat burning in brown
adipose tissue and mitochondrial dysfunction (3, 7). Several
studies showed that iPLA2␥ KO mice display multiple bioenergetic dysfunctional phenotypes. For example, iPLA2␥ deletion
induced profound alterations in hippocampal phospholipid
metabolism and mitochondrial phospholipid homeostasis,
resulting in enlarged and degenerating mitochondria, leading
to enhanced autophagy and cognitive dysfunction (8). Another
recent study showed that genetic ablation of iPLA2␥ prevented
obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation (9). Taken together, these reports confirm an obligatory
role for iPLA2␥ in mitochondrial lipid metabolism and membrane structure, perturbation of which may profoundly influence fatty acid ␤-oxidation, oxygen consumption, energy
expenditure, and, thus, tissue homeostasis. Despite the recent
advances in studying the pathophysiological role of iPLA2␥ in
the brain, liver, heart, and skeletal muscles (7, 8, 10, 11), the
pathophysiological roles of iPLA2␥ in the kidney are poorly
understood.
Visceral glomerular epithelial cells (GECs), also known as
podocytes, are highly differentiated cells of the kidney glomerulus, which play a critical role in the maintenance of glomerular
permselectivity (12–14). Podocytes have a complex morphology that is characterized by cell bodies with projecting foot
processes, which adhere to the glomerular basement membrane (GBM). The unique shape of podocytes is supported by
the actin cytoskeleton, which allows podocytes to alter their
shape dynamically (12, 15). In many renal diseases, changes in
the size and surface charge of podocytes contribute to the
development of proteinuria. Specifically, proteinuria is associated with the disruption of the foot processes with the concomitant transformation of the actin cytoskeleton (12–15). Thus,
the intricate structure of foot processes is central to their function of maintaining glomerular permselectivity (i.e. filtration of
plasma but restriction of proteins). Various forms of glomerulonephritis, including those induced by antibody and compleVOLUME 291 • NUMBER 28 • JULY 8, 2016
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Glomerular visceral epithelial cells (podocytes) play a critical
role in the maintenance of glomerular permselectivity. Podocyte injury, manifesting as proteinuria, is the cause of many glomerular diseases. We reported previously that calcium-independent phospholipase A2␥ (iPLA2␥) is cytoprotective against
complement-mediated glomerular epithelial cell injury. Studies
in iPLA2␥ KO mice have demonstrated an important role for
iPLA2␥ in mitochondrial lipid turnover, membrane structure,
and metabolism. The aim of the present study was to employ
iPLA2␥ KO mice to better understand the role of iPLA2␥ in
normal glomerular and podocyte function as well as in glomerular injury. We show that deletion of iPLA2␥ did not cause
detectable albuminuria; however, it resulted in mitochondrial
structural abnormalities and enhanced autophagy in podocytes
as well as loss of podocytes in aging KO mice. Moreover, after
induction of anti-glomerular basement membrane nephritis in
young mice, iPLA2␥ KO mice exhibited significantly increased
levels of albuminuria, podocyte injury, and loss of podocytes
compared with wild type. Thus, iPLA2␥ has a protective functional role in the normal glomerulus and in glomerulonephritis.
Understanding the role of iPLA2␥ in glomerular pathophysiology provides opportunities for the development of novel therapeutic approaches to glomerular injury and proteinuria.

Podocyte Injury in iPLA2␥ Knock-out Mice

Experimental Procedures
Materials—A mouse albumin ELISA quantification kit was
purchased from Bethyl Laboratories (Montgomery, TX). The
creatinine assay kit was from Cayman Chemical Co. (Ann
Arbor, MI). Tissue culture media and Lipofectamine 2000 were
from Invitrogen (Burlington, Canada) and Wisent (Saint-JeanBaptiste, Canada). Electrophoresis reagents were from Bio-Rad
(Mississauga, Canada), and GE Healthcare (Baie d’Urfé, Canada). Rabbit anti-Wilms tumor-1 (WT1; catalog no. 192), goat
anti-synaptopodin (catalog no. 21537), rabbit anti-GRP94 (catalog no. 11402), and rat anti-GRP78 (BiP; catalog no. 13539)
antibodies were purchased from Santa Cruz Biotechnology.
Goat anti-podocalyxin antibody (catalog no. AF1556) was from
JULY 8, 2016 • VOLUME 291 • NUMBER 28

R&D Systems (Minneapolis, MN). Rabbit anti-microtubule-associated protein light chain 3B (LC3; catalog no. 2775), rabbit
anti-phospho-AMP-activated protein kinase (AMPK)-␣ (Thr172; catalog no. 2531), and rabbit anti-AMPK␣ (catalog no.
2532) antibodies were from Cell Signaling Technology (Danvers, MA). FITC-conjugated rabbit anti-sheep IgG (catalog no.
31509) was from Zymed Laboratories Inc. (South San Francisco, CA). FITC-conjugated goat anti-mouse complement C3
(catalog no. 55500) was purchased from MP Biomedical (Santa
Ana, CA). MitoTracker Red CMXRos was from Thermo Fisher
Scientific (Burlington, ON). Plasmid pBABE-puro mCherryEGFP-LC3B was from Addgene (catalog no. 22418) (23). Plasmid “mito-YFP” (cytochrome c oxidase-subunit IV fused with
yellow fluorescent protein; catalog no. 10089272) was from the
American Type Culture Collection (Manassas, VA). Sheep
anti-rat GBM, and rabbit anti-nephrin antisera were described
previously (24, 25).
Mice—iPLA2␥ KO mice in a C57BL/6 background were produced, bred, and genotyped, as described previously (7). Animal
protocols were reviewed and approved by the McGill University Animal Care Committee. Conscious animals fed ad libitum
were weighed, and urine samples were collected at various time
points after weaning up to 12–16 months of age.
Assays for Albuminuria and Serum Creatinine—Mouse urine
albumin concentration was quantified using an enzyme-linked
immunosorbent assay kit according to the manufacturer’s
instructions. The assay utilizes urine samples diluted 1:5000 or
1:150,000, analyzed in a plate reader set at 450 nm. Urine creatinine concentration was measured using a colorimetric assay
kit according to the manufacturer’s instructions. The assay measures creatinine in urine samples diluted 1:15, using a picric
acid-based method, and analyzed on a plate reader set at 490 –
500 nm. Excretion of albumin is expressed as the albumin/creatinine ratio. Serum creatinine was measured using an enzymatic assay on the Olympus AU5822 chemistry system
(Beckman Coulter) in the Biochemistry Laboratory of the
McGill University Health Centre.
Induction of Anti-GBM Nephritis in Mice—Anti-GBM
nephritis was induced in 3– 4-month-old iPLA2␥ KO or WT
mice by a single tail intravenous injection of 5–10 l of sheep
anti-GBM antiserum diluted in 0.1 ml of sterile saline (24, 26).
After 24 h, mice were sacrificed by CO2 asphyxiation, and kidneys were dissected. Kidney sections were collected for immunofluorescence, light, and electron microscopy (see below).
Glomeruli were isolated utilizing a differential sieving technique (24).
Cell Culture and Complement Cytotoxicity Assay—Mouse
GECs were derived from iPLA2␥ KO mice and WT control. The
detailed method and characterization of the cells was published
previously (21). Briefly, by quantitative reverse polymerase
chain reaction, iPLA2␥ mRNA was present in cells derived from
WT mice but was completely absent in cells from KO mice. WT
and KO cell lines expressed the podocyte proteins, synaptopodin and nephrin (12, 14, 21). The cells were cultured on plastic
substratum in K1 medium and were used at passages 2–20.
Cells were transfected with pBABE-puro mCherry-EGFPLC3B, using Lipofectamine 2000 reagent according to the manufacturer’s instructions.
JOURNAL OF BIOLOGICAL CHEMISTRY
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ment, are associated with podocyte injury, which may lead to
foot process effacement, detachment from the GBM, or apoptosis, with consequent impairment of glomerular function
and permselectivity (proteinuria), and glomerulosclerosis (13,
16 –18).
Previously, we characterized the expression and activity of
iPLA2␥ in cultured GECs and characterized the mechanisms of
iPLA2␥ activation by complement C5b-9 (19, 20). In GECs, we
demonstrated that iPLA2␥ is localized at the endoplasmic reticulum (ER) and mitochondria, and this localization was dependent on the N-terminal region of iPLA2␥ (20). Complement
stimulated the activation of iPLA2␥, which was mediated via the
extracellular signal-regulated kinase and p38 pathways. Stimulation of iPLA2␥ was dependent on phosphorylation of Ser-511
and/or Ser-515 via MNK1 (MAPK-interacting kinase 1) (20). In
addition to characterizing these signaling pathways, we showed
that overexpression of iPLA2␥ in cultured GECs reduced complement-mediated GEC injury (19) as well as injury by tunicamycin, which was associated with augmentation of the ATF6
(activating transcription factor 6) pathway of the unfolded protein response in the ER (21). In other cells, such as primary
cultures of rabbit renal proximal tubules cells, knockdown of
iPLA2␥ expression increased lipid peroxidation and impaired
mitochondrial function (22). Likewise, knockdown of iPLA2␥
in C2C12 myoblasts also caused an elevation of lipid peroxidation and reduction of ATP synthesis (11). Thus, the function of
iPLA2␥ can be cytoprotective, and depending on the cellular
context, it may involve ER stress or removal of peroxidized
phospholipid from the mitochondrial membrane, thereby preserving membrane integrity.
So far, we and others have provided considerable insight into
the functions of iPLA2␥ in cultured cell lines, but information
on the functional role of iPLA2␥ in the kidney is lacking. The
aim of the present study was to employ iPLA2␥ KO mice to
better understand the role of iPLA2␥ in normal glomerular/
podocyte function and in glomerular injury. We show that deletion of iPLA2␥ did not cause albuminuria; however, it resulted
in mitochondrial structural abnormalities and enhanced
autophagy in podocytes of aging mice. Moreover, after induction of anti-GBM nephritis in young mice, iPLA2␥ KO mice
exhibited significantly increased levels of albuminuria, podocyte injury, and loss of podocytes compared with WT mice. Our
results indicate that iPLA2␥ has a protective functional role in
the normal glomerulus and in glomerulonephritis.

Podocyte Injury in iPLA2␥ Knock-out Mice
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The threshold intensity was set at the end of the histogram
declining slope (thereby only including the brightest fluorescent puncta and omitting cellular features and background).
The area of LC3-II puncta was set between 0.2 and 25 m2. The
number of particles/puncta and total cross-sectional area of the
particles/puncta whose areas fell within the set range of 0.2–25
m2 were measured. Results were normalized per 1000 m2 of
cell area. The image calculator function (subtract operation)
was used to calculate the mCherry-LC3-II particles/puncta that
did not colocalize with GFP-LC3-II.
Light and Electron Microscopy—For light microscopy, kidney
tissue was fixed in formalin, and was processed and embedded
in paraffin according to conventional techniques. Sections were
stained with periodic acid Schiff at the Goodman Cancer
Research Center Histology Facility, McGill University. Electron
microscopy was carried out at the McGill University Facility for
Electron Microscopy Research. Briefly, kidney tissue was fixed
in 2.5% glutaraldehyde in 0.1 mol/liter sodium cacodylate
buffer containing 0.1% CaCl2, pH 7.4. Samples were washed and
postfixed with 1% aqueous OsO4 and 1.5% aqueous potassium
ferrocyanide. Then samples were dehydrated with serially
increasing concentrations of acetone (from 30 to 100%) and
were infiltrated with epon/acetone. Sections of 90 –100 nm
were placed onto grids and stained with uranyl acetate and
Reynold’s lead. Samples were viewed with an FEI Tecnai 12
transmission electron microscope operating at an accelerating
voltage of 120 kV and equipped with an AMT XR80C CCD
camera.
Quantification of Foot Process Effacement and Glomerular
Surface Area—Randomly selected electron micrographs were
used for morphometric analysis of foot process effacement, as
described previously (27, 28), using ImageJ software. The mean
width of the foot process (FPW) was calculated according to the
formula (27), FPW ⫽ ( ⫻ glomerular basement membrane
length)/(4 ⫻ foot process number).
A greater foot process width value represents increased foot
process effacement. Three capillary loops from 2–3 glomeruli/
mouse were quantified, and the results from 3–5 mice/group
were pooled and analyzed. Glomerular cross-sectional surface
area was measured in light micrographs of KO and WT mice,
using ImageJ software.
Immunoblot Analysis—Lysates of isolated glomeruli (24)
were prepared in buffer containing 1% Triton X-100, 125 mM
NaCl, 10 mM Tris (pH 7.4), 1 mM EGTA, 2 mM Na3VO4, 10 mM
sodium pyrophosphate, 25 mM NaF, and protease inhibitor
mixture (Bioshop, Burlington, Canada). Equal amounts of
lysate proteins were dissolved in Laemmli buffer and were subjected to SDS-PAGE under reducing conditions. Proteins were
then electrophoretically transferred onto nitrocellulose or polyvinyl difluoride membranes and blocked at 22 °C for 1 h with
5% BSA in buffer containing 10 mM Tris, pH 7.5, 50 mM NaCl,
2.5 mM EDTA, and 0.05% Tween 20. The membrane was then
incubated with primary and secondary antibodies. Bands were
detected by an enhanced chemiluminescence system (GE
Healthcare, Mississauga, Canada). Quantitative densitometry
was performed using ImageJ (25).
Statistics—Data are presented as mean ⫾ S.E. One-way analysis of variance was used to determine significant differences
VOLUME 291 • NUMBER 28 • JULY 8, 2016
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Rat GECs were cultured as described above and were characterized previously (19 –21, 26). These cells were employed in
the complement cytotoxicity assay (19, 20, 26). Briefly, rat
GECs were incubated with rabbit anti-GEC antiserum (5%, v/v)
in modified Krebs-Henseleit buffer containing 145 mM NaCl, 5
mM KCl, 0.5 mM MgSO4, 1 mM Na2HPO4, 0.5 mM CaCl2, 5 mM
glucose, and 20 mM Hepes, pH 7.4, for 30 min at 22 °C. The cells
were then incubated for 40 min at 37 °C with normal human
serum (with full complement activity) or heat-inactivated
(decomplemented) human serum (incubated at 56 °C for 60
min) in controls. Complement-mediated cytolysis was determined by measuring lactate dehydrogenase (LDH) release (19,
26). Specific LDH release was calculated as (NS ⫺ HIS)/(100 ⫺
HIS), where NS represents the percentage of total LDH released
into cell supernatants in incubations with normal serum, and
HIS represents the percentage of total LDH released in incubations with heat-inactivated serum.
Immunofluorescence Microscopy—Kidney poles were snapfrozen using HistoPrep (Fisher Scientific, Ottawa, Canada) in
isopentane (⫺80 °C). Cryostat sections (4 m) were cut and
stored at ⫺80 °C. Frozen sections were then fixed in 4% paraformaldehyde and blocked with 5% normal rabbit serum (for
sheep IgG) or goat serum (for C3) in 5% BSA or in 5% BSA alone
(for synaptopodin, podocalyxin, and nephrin antibodies). The
blocking solution was replaced with a fluorophore-conjugated
primary antibody or, alternatively, with an unconjugated primary antibody, followed by a fluorophore-conjugated secondary antibody. Incubations with primary antibodies ranged from
2 h to overnight (4 or 22 °C). Incubations with secondary antibodies were 1 h at 22 °C. Sections were examined with a Zeiss
AxioObserver fluorescence microscope with visual output connected to an AxioCam digital camera. Images of multiple glomeruli were collected from series of images derived from different focal planes (z-stack). To allow comparisons of fluorescence
intensity, all images were taken at the same exposure. Fluorescence intensity was quantified using the histogram function of
Adobe Photoshop or ImageJ software (National Institutes of
Health, Bethesda, MD). Results are expressed in arbitrary units.
For WT1 immunofluorescence, frozen sections were fixed
with 4% paraformaldehyde and then immersed in 10 mmol/
liter sodium citrate, pH 6.0, for 8 min at 100 °C. After cooling to
22 °C, sections were blocked with 10% normal goat serum and
were incubated with rabbit anti-WT1 antibody (4 °C, overnight), followed by rhodamine-goat anti-rabbit IgG (22 °C, 1 h).
WT1-positive cells were quantified by visual counting.
To visualize mitochondria, cells on coverslips were incubated for 15–30 min at 37 °C with MitoTracker Red CMXRos
(25 nM). Hoechst H33342 (1 g/ml) was added for the final 5
min to label nuclei. Cells were then fixed with paraformaldehyde. After washing, coverslips were mounted onto glass slides
and visualized with a fluorescence microscope (20).
GFP and mCherry-LC3-II puncta in cells can be readily distinguished from background fluorescence and quantified using
ImageJ software. Green and red images were separately converted to grayscale. Cell contours on grayscale images were
selected with the freehand tool, and the area of the cross-section was measured. Then image histogram plots were obtained,
representing the range of pixel brightness values in each image.

Podocyte Injury in iPLA2␥ Knock-out Mice

FIGURE 1. iPLA2␥ deletion does not alter urinary albumin excretion in
mice. A, urinary albumin/creatinine ratio. Each point represents the urine
collection of a single mouse taken at monthly intervals between 4 and 16
months (mo) of age. WT and iPLA2␥ KO mice were divided into groups according to sex (male (M) and female (F)). There are no significant differences
among the groups. B, glomerular surface area was measured in light micrographs of KO and WT mice (age 10 –11 months). There were no significant
differences between groups (3 mice/group; 14 –24 measurements/group).
Error bars, S.E.

Results
iPLA2␥ Deletion Does Not Affect Baseline Urinary Albumin
Excretion—General phenotypic features of mice null for
iPLA2␥ were described previously (7, 11). In keeping with the
earlier report, modest growth retardation was visible in KO
mice after 2 months of age. At 3– 4 months, iPLA2␥ KO animals
(males and females) had a mean weight of 22.09 ⫾ 0.75 g versus
26.02 ⫾ 0.84 g for WT (p ⬍ 0.005, n ⫽ 9 –10 mice/group).
There was no significant difference in weight between males
and females within the same groups. To determine whether
deletion of iPLA2␥ can affect glomerular permeability and
induce proteinuria, we quantified the urine albumin/creatinine
ratio. Mice at 4 –7 months of age showed a low albumin/creatinine ratio, and there was no significant difference between KO
and WT mice (Fig. 1A). Urine albumin tended to be slightly
higher in male mice compared with females. The albumin/creatinine ratio between WT and age/sex-matched KO mice did
not differ significantly up to 16 months of age (Fig. 1). Serum
creatinine values were 9.3 ⫾ 0.7 M in 10 –12-month-old
iPLA2␥ KO mice and 12.1 ⫾ 0.9 M in WT (p ⫽ 0.02; 7– 8
mice/group). The lower mean value in the KO mice is consistent with lower body weight. Light microscopy (periodic acid
Schiff staining) showed normal glomerular and tubular morphology in both WT and KO mice 10 –12 months of age (results
not shown). To confirm the visual impression, glomerular surface area was measured in light micrographs of KO and WT
mice. There were no significant differences between groups
(Fig. 1B).
iPLA2␥ Deletion Induces Mitochondrial Damage and
Autophagy in Podocytes—Given that iPLA2␥ is localized in
GECs at the ER and mitochondria (20), we hypothesized that
deletion of iPLA2␥ may induce abnormalities in these organelles. Kidneys of iPLA2␥ KO and WT control mice at age 10 –11
months were examined by electron microscopy. Podocyte foot
JULY 8, 2016 • VOLUME 291 • NUMBER 28
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among groups. Where significant differences were found, individual comparisons were made between groups using Student’s
t test and adjusting the critical value according to Bonferroni’s
method. Student’s t test was used to determine significant differences between two groups.

processes appeared structurally intact in both iPLA2␥ KO mice
(Fig. 2A) and WT controls (not shown). WT mice showed no
apparent glomerular abnormalities, and in particular, podocytes showed intact cell organelles, including the ER and mitochondria (Fig. 2B). In contrast, some podocytes in iPLA2␥ KO
mice showed microvillous transformation and membrane
vesiculation, compatible with podocyte injury (Fig. 2C). The
striking observation in iPLA2␥ KO mice was that podocytes
showed abnormal mitochondria and the presence of
autophagic vacuoles (Fig. 2, D–I). The mitochondrial abnormalities were widespread and included aggregation, disruption
of membranes, and loss/rearrangement of cristae (Fig. 2, F and
H), whereas some mitochondria appeared to be undergoing fission (Fig. 2F).
We analyzed all high power electron micrographs to quantify
damaged mitochondria and autophagosome structures in
podocytes. In 5 iPLA2␥ KO mice, damaged mitochondria were
observed in 54% of the micrographs, and damaged autophagosomes were seen in 17%. Forty percent of the micrographs
showed both normal mitochondria and an absence of autophagosomes (35 high power electron micrographs were examined
in total). In three WT mice, there were no damaged mitochondria nor any autophagosomes (17 electron micrographs were
examined).
It should also be noted that, unlike podocytes, mitochondria
in parietal epithelial cells, glomerular endothelial cells, and
proximal tubular epithelial cells in iPLA2␥ KO mice appeared
normal (Fig. 2, D, H, and J). In contrast to the mitochondria in
iPLA2␥ KO podocytes, the ER and nuclei appeared intact (Fig.
2, E–I). Quantification of foot process width in iPLA2␥ KO and
WT mice demonstrated modest but significant widening of
foot processes in the KO (Fig. 2K). Thus, deletion of iPLA2␥
in mice induces prominent mitochondrial abnormalities,
autophagy, and modest widening of the foot processes and
plasma membrane changes in podocytes.
iPLA2␥ Deletion Induces Podocyte Loss but Not ER Dysfunction in Podocytes—The above results showed that iPLA2␥ deletion affected podocyte ultrastructure; consequently, podocyteassociated proteins that are believed to play key roles in
maintaining ultrastructure and slit diaphragms (nephrin, synaptopodin, and podocalyxin) (12, 14, 26, 29) were examined by
immunofluorescence microscopy and immunoblot analysis.
The podocyte nuclear marker, WT1, was also studied as an
index of podocyte number (12, 14, 26, 29). Kidney sections from
iPLA2␥ KO and WT mice (age 10 –11 months) were stained
with specific antibodies. Synaptopodin, nephrin, and podocalyxin showed an immunofluorescence staining pattern consistent with expression in podocytes in glomeruli of iPLA2␥ KO
and WT mice, although the intensity of synaptopodin was
reduced in the KO (Fig. 3A). Quantification of glomerular fluorescence intensity showed that synaptopodin staining was significantly lower in iPLA2␥ KO glomeruli compared with WT
(Fig. 3B). Fluorescence intensities of nephrin and podocalyxin
staining did not differ significantly between WT and iPLA2␥
KO mouse glomeruli, although both tended to decrease in the
KO (Fig. 3, C and D).
To determine whether deletion of iPLA2␥ induces podocyte
loss, we quantified the number of podocyte nuclei in glomeruli

Podocyte Injury in iPLA2␥ Knock-out Mice
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of iPLA2␥ KO and WT mice using WT1 immunostaining.
There was a ⬃25% decrease in the number of WT1-positive
cells in iPLA2␥ KO glomeruli compared with control (Fig. 3, A
and E), indicating that deletion of iPLA2␥ induced a loss of
podocytes. This result does not, however, exclude the possibility that a reduction in WT1-positive cells might have been
related to injury instead of loss of cells.
Immunoblotting of glomerular lysates showed that expression of nephrin and podocalyxin proteins was not significantly
different between iPLA2␥ KO and WT mice. Synaptopodin was
reduced in the KO (Fig. 4, A–D), consistent with the immunofluorescence staining (Fig. 3, B–D). Nephrin undergoes important post-translational modifications in the ER before export to
the plasma membrane (25). By SDS-PAGE, nephrin migrates as
a doublet of ⬃180 kDa. The upper band represents the fully
glycosylated, mature form of nephrin, whereas the lower band
is an immature form found in the ER (25, 26). To address the
role of iPLA2␥ in ER function in vivo, we examined the pattern
of nephrin glycosylation in isolated glomeruli by immunoblotting. There were no apparent differences in nephrin glycosylation between iPLA2␥ KO and WT mice (Fig. 4B, bottom), sug-

gesting that ER function remained intact despite iPLA2␥
deletion.
In a previous study (21), we demonstrated that in cultured
GECs, iPLA2␥, via its localization at the ER, amplified the activation of the ATF6 pathway of the unfolded protein response.
Amplification of ATF6 resulted in the up-regulation of the ER
chaperones, GRP78 (BiP) and GRP94 (21). Conversely, deletion
of iPLA2␥ blunted these responses, as shown in cultured GECs
derived from WT and iPLA2␥ KO mice (21). Therefore, we
undertook to examine the expression of ER chaperones in
podocytes in vivo by immunoblotting. Unexpectedly, there was
no significant difference in the glomerular GRP94 expression
between WT and iPLA2␥ KO mice (Fig. 4, A and E). A similar
result was obtained with GRP78 (BiP) expression (result not
shown). Therefore, either differences in ER chaperone expression between WT and iPLA2␥ KO mice were too small to be
detected in vivo, or additional factors regulate the expression of
these proteins in vivo compared with in cultured cells.
iPLA2␥ Deletion Reduces Mitochondrial Function—The electron micrographs of iPLA2␥ KO mice showed striking mitochondrial abnormalities (Fig. 2). To determine whether these

FIGURE 2. Kidney cell ultrastructure in 10 –11-month-old mice (electron microscopy). A, podocyte foot processes in iPLA2␥-KO mice appeared structurally
intact. B, podocyte from a WT, control mouse shows intact cell organelles, including mitochondria. C, podocytes from an iPLA2␥ KO mouse show microvillous
transformation and membrane vesiculation (arrows). D–I, podocytes from iPLA2␥-KO mice show abnormal mitochondria and autophagic vacuoles. F and H,
magnified views of the areas in E and G outlined by boxes, respectively. Mitochondria in podocytes show aggregation, disruption of membranes, and loss of
cristae (arrowheads in F and H), whereas some mitochondria appear to be undergoing fission (F). In D and I, the closed arrows point to autophagosomes in
podocytes. Mitochondria in a parietal epithelial cell (open arrow, D) and a glomerular endothelial cell (open arrow, H) appear normal. The ER (F and H) and nuclei
(E–I) in podocytes appear intact. J, proximal tubular epithelial cell from an iPLA2␥-KO mouse shows normal mitochondria. The brush border is seen on the top
right of the photomicrograph. Bar, 500 nm. Glomeruli were examined in five KO and three WT mice, 2–3 glomeruli/mouse. K, quantification of foot process
width in iPLA2␥-KO and WT mice. *, p ⬍ 0.0005 KO versus WT (21–22 measurements/group). Error bars, S.E.
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FIGURE 3. Expression of synaptopodin, nephrin, podocalyxin, and WT1 in 10 –11-month-old WT and iPLA2␥-KO mice. A, kidney sections were stained
with specific antibodies and were examined by immunofluorescence microscopy. Bar, 20 m. B–D, quantification of fluorescence intensity in arbitrary units
(3–7 glomeruli/mouse in three KO and two WT mice, or 11–18 glomeruli/group, were analyzed). B, synaptopodin: p ⬍ 0.0002, KO versus WT. E, WT1-positive
(pos) nuclei: p ⬍ 0.0001, KO versus WT (6 –12 glomeruli/mouse in three KO and two WT mice, or 34 –55 glomeruli/group, were analyzed). Error bars, S.E.
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mitochondrial abnormalities were associated with impaired
mitochondrial function in vivo, we monitored phosphorylation
of AMPK, a ubiquitous serine/threonine kinase (30, 31). During
periods of cellular stress, particularly when there is a decrease in
ATP, and increases in ADP and AMP, binding of ADP or AMP
activates AMPK by facilitating phosphorylation and inhibiting
dephosphorylation of Thr-172 in the ␣-subunit. Thus, AMPK
acts as a sensor of cell energy stores, and phosphorylation of
AMPK is inversely related to the cell’s ATP level. The mean
glomerular phospho-AMPK level was clearly increased in
iPLA2␥ KO mice compared with control, although there was
some variability among animals (Fig. 4, A and F). This result is
in keeping with reduced ATP generation by mitochondria in
podocytes.
To provide additional support for the conclusion that deletion of iPLA2␥ impaired mitochondrial function, we examined
Mitotracker Red CMXRos staining in cultured GECs produced
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from WT and iPLA2␥ KO mice (21). MitoTracker Red
CMXRos is a fluorescent dye that stains mitochondria in live
cells, and its accumulation is dependent on the mitochondrial
membrane potential. In WT cells, the mitochondria stained
brightly and localized diffusely throughout the cytoplasm (Fig.
5, A and C). In these cells, the mitochondria appeared as short
tubular structures, and they did not form long filaments. In
most of the iPLA2␥ KO cells, cytoplasmic staining was faint or
absent, and the mitochondria appeared aggregated in a perinuclear distribution (Fig. 5, A and C). The latter resembled the
staining of Mitotracker Red CMXRos in WT GECs that had
been treated with antimycin A (Fig. 5A). This drug disrupts
mitochondrial function by blocking the electron transport
chain and results in loss of fluorescent probe from mitochondria (32). It should be noted that, in contrast to the Mitotracker
Red CMXRos staining, there were no differences in the expression of transfected mito-YFP (YFP targeted to mitochondria)
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FIGURE 4. Effect of iPLA2␥ deletion on expression of nephrin (fully glycosylated and ER forms), podocalyxin, GRP94, synaptopodin (synpo), phosphoAMPK (pAMPK), AMPK, and LC3-I and -II. Glomeruli were isolated from 10 –11-month-old WT and iPLA2␥-KO mice. Lysates were immunoblotted, as indicated. A, representative immunoblots. The white lines in the top panel indicate reassembly of noncontiguous gel lanes. There were no adjustments made to the
digital images among the lanes that would alter the information in the panels. B–G, densitometric quantification. B, C, and E, there were no significant
differences in the expression of fully glycosylated nephrin (top nephrin band), nephrin maturation (ratio of top to bottom band), podocalyxin, and GRP94
between groups (3–5 mice/group). D, synaptopodin was significantly lower in KO glomeruli. *, p ⬍ 0.05, 3 mice/group. F, the ratio of phospho-AMPK/AMPK was
significantly greater in KO glomeruli. *, p ⬍ 0.04, 4 mice/group. G, the ratio of LC3-II/LC3-I was significantly greater in KO mice. *, p ⫽ 0.01, 7–9 mice/group.
Because the intensity of the LC3-I band in A was relatively weak, the immunoblot was repeated using a longer exposure time. This resulted in enhanced signals
in LC3-I bands, although the signals of the LC3-II bands became oversaturated. Nevertheless, the LC3-II/LC3-I ratio remained significantly elevated in the KO
mice compared with WT (results not shown). Error bars, S.E.
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between iPLA2␥ KO and WT GECs (Fig. 5, B and C). This
reflects similar mitochondrial mass in the two cell lines. Thus,
the reduced Mitotracker Red CMXRos staining in iPLA2␥ KO
GECs indicates impaired mitochondrial function.
iPLA2␥ Deletion Induces Autophagy in GECs—Ultrastructural examination of iPLA2␥ KO mice showed autophagic vacuoles in some podocytes (Fig. 2, C–E). The extent of lipidation
of LC3 (i.e. conversion of LC3-I to LC3-II) is widely used to
monitor autophagy, and typically, an increase in the ratio of
LC3-II to LC3-I correlates with the number of active autophagosomes (33). We employed immunoblotting to monitor the
levels of LC3-I and LC3-II in glomeruli of WT and iPLA2␥ KO
mice (Fig. 4A). Densitometric quantification showed that the
LC3-II/LC3-I ratio was markedly greater in iPLA2␥ KO glomeruli compared with WT control (Fig. 4G). These results are in
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FIGURE 5. Mitochondrial function in cultured GECs. A, WT or iPLA2␥ KO
GECs were incubated with Mitotracker Red CMX-Ros (25 nM for 30 min). In
most WT cells, the mitochondria stained brightly and were found diffusely
throughout the cytoplasm. In many iPLA2␥ KO cells, cytoplasmic staining was
faint or absent, and the mitochondria were collapsed in a perinuclear distribution. The latter resembled the staining of Mitotracker Red in WT podocytes
that had been treated with antimycin A (WT⫹A; 10 M for 30 min) to induce
mitochondrial dysfunction. Bar, 15 m. Cells showing diffuse, perinuclear,
and intermediate Mitotracker Red CMX-Ros staining patterns are quantified
in the graph (C; intermediate pattern indicates perinuclear localization but
with some diffuse staining). *, p ⬍ 0.0005; **, p ⬍ 0.0001, KO versus WT (170 KO
cells and 228 WT cells). B, GECs were transiently transfected with mito-YFP.
Images were obtained after 24 h. In transfected cells, expression of mito-YFP
was comparable between KO and WT cells. The inset (C) shows quantification
of YFP fluorescence intensity in arbitrary units (a.u.) (22–30 cells/group). Error
bars, S.E.

keeping with the presence of autophagosomes in podocytes in
the electron micrographs of iPLA2␥ KO mice.
There are some limitations to quantifying enhanced
autophagic flux in vivo. Thus, to confirm enhanced autophagy
and the changes in LC3 in glomeruli, we measured the conversion of LC3-I to LC3-II in cultured GECs from WT and iPLA2␥
KO mice (21). GECs were incubated with or without chloroquine for 2 or 6 h. Chloroquine blocks the fusion of autophagosomes with lysosomes, which forms autolysosomes, and therefore prevents autolysosomal protein degradation, allowing us to
compare the rate of autophagosome formation in WT and
iPLA2␥ KO GECs (33). GEC lysates were immunoblotted with
anti-LC3 antibody. Deletion of iPLA2␥ in cultured GECs
resulted in a significantly greater increase in the ratio of LC3II/LC3-I in KO cells, compared with WT, in the presence of
chloroquine at 6 h (Fig. 6A). This result is consistent with
enhanced autophagy and is in keeping with the findings in vivo
(Fig. 4G).
Conversion of LC3-I to LC3-II in cultured GECs was also
addressed by monitoring the formation of LC3-II puncta by
fluorescence microscopy (23, 33). In these experiments, GECs
were transfected with mCherry-GFP-LC3B, encoding LC3
tagged with two fluorescent proteins, mCherry and GFP.
mCherry- or GFP-LC3-I is cytoplasmic. GFP is quenched in an
acidic environment (i.e. in lysosomes), but mCherry is acidstable; thus, formation of GFP-LC3-II puncta reflects formation of autophagosomes, whereas mCherry-LC3-II puncta
reflect formation of autophagosomes and their fusion with
lysosomes (23, 33). In resting WT GECs, the distribution of
mCherry- and GFP-LC3-I was in a cytoplasmic pattern (Fig.
6B). Quantification confirmed the visual impression that resting cells contained relatively few puncta and that the puncta
constituted only a minimal proportion of cell area (Fig. 6C,
second columns). Increased formation of GFP-LC3-II puncta
and, to a lesser extent, mCherry-LC3-II puncta that did not
colocalize with GFP was evident in iPLA2␥ KO GECs even in
the absence of chloroquine (Fig. 6, B and C, first columns). The
addition of chloroquine markedly enhanced GFP-LC3-II
puncta in KO cells (Fig. 6, B and C, third column), consistent
with the formation of autophagosomes in the KO cells. Chloroquine slightly increased GFP-LC3-II puncta in WT cells, but
the change was not significant (Fig. 6, B and C, fourth column).
In the presence of chloroquine, prominent mCherry-LC3-II
puncta were also increased in KO cells, and most mCherry
puncta colocalized with GFP (Fig. 6B). These results reflect
LC3-II at autophagosomes and to a minor extent in lysosomes
and thus confirm enhanced autophagy in iPLA2␥ KO GECs.
iPLA2␥ Deletion Exacerbates Albuminuria in Anti-GBM
Nephritis—Our previous studies in cultured GECs demonstrated a protective role for iPLA2␥ in injury induced by complement (19) and tunicamycin (21). In addition, the above
experiments showed that in vivo, iPLA2␥ is essential to the
maintenance of podocyte integrity under basal conditions. Specifically, deletion of iPLA2␥ induced mitochondrial abnormalities with autophagy in older mice. In the next set of experiments, we examined whether induction of podocyte injury with
anti-GBM antibody would reveal a protective phenotype of
iPLA2␥ in young mice. C5b-9-induced GEC/podocyte injury
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and proteinuria are hallmarks of heterologous mouse antiGBM nephritis. Anti-GBM antibody binds in part to podocyte
antigens in vivo, and heterologous phase proteinuria is abolished by C6 deficiency, indicating a key role of C5b-9 (24, 34,
35). In previous studies, we determined that administration of
5–10 l of sheep anti-GBM antiserum induces mild to moder-
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FIGURE 6. Autophagy is enhanced in iPLA2␥ KO GECs in culture. A, deletion
of iPLA2␥ in GECs increases the ratio of LC3-II/LC3-I. WT or iPLA2␥ KO GECs
were incubated with or without chloroquine (CQ; 15 M) for 2 or 6 h. Shown is
a representative immunoblot of GEC lysates. Values below the LC3 immunoblot indicate mean ⫾ S.E. ratios of LC3-II/LC3-I in the eight groups (four experiments). *, p ⬍ 0.03 KO versus WT at 6 h (⫹CQ). B, iPLA2␥ KO GECs in culture
show greater numbers of mCherry- and GFP-LC3-II puncta compared with WT
cells (representative fluorescence micrographs). GECs were transiently transfected with mCherry-GFP-LC3B (0.1 g of plasmid DNA/well). After 24 h, cells
were untreated (Untr; ⫺) or treated with 15 M chloroquine (CQ; ⫹). Images
were obtained after 6 h. Bar, 25 m. The inset (KO-CQ, merged) is an enlargement of the area within the square. C, quantification of GFP-LC3-II puncta and
GFP-LC3-II puncta area. Results were normalized per 1000 m2 of cell area. In
the bars showing the GFP ⫹ mCherry LC3-II puncta/area, the GFP and
mCherry components are above and below the white line, respectively. The
mCherry component is that which did not colocalize with GFP. *, p ⬍ 0.005,
KO-untreated versus WT-untreated. **, p ⬍ 0.0001, KO-CQ versus WT-CQ; p ⬍
0.0001, KO-CQ versus KO-Untr; and ***, p ⬍ 0.01 WT-CQ versus WT-untreated.
⫹, p ⬍ 0.002 KO-untreated versus WT-untreated; ⫹⫹, p ⬍ 0.0001 KO-CQ
versus WT-CQ and p ⬍ 0.0001 KO-CQ versus KO-untreated (11–12 cells/
group). Error bars, S.E.

ate albuminuria (26). Therefore, iPLA2␥ KO and WT mice (age
3– 4 months) were injected with anti-GBM antiserum, and
additional mice in each group were injected with saline (control). Urine samples were collected just before administration
of antibody and after 24 h. Both WT and iPLA2␥ KO mice
developed albuminuria 24 h after induction of anti-GBM
nephritis. However, iPLA2␥ KO mice exhibited significantly
higher levels of albuminuria compared with WT (Fig. 7A).
Deposition of anti-GBM antibody and activation of complement were assessed by immunofluorescence microscopy.
There was prominent linear deposition of sheep anti-GBM IgG
along the glomerular capillary walls in both WT and iPLA2␥
KO mice (Fig. 7B). Glomerular C3 staining was slightly fainter,
compared with IgG, but was clearly present in both groups of
mice (Fig. 7B). Quantification of IgG and C3 fluorescence
intensity did not demonstrate significant differences between
the two groups (Fig. 7C). Therefore, the increased albuminuria
in iPLA2␥ KO mice occurred despite equal glomerular antiGBM antibody and C3 deposition in WT and iPLA2␥ KO mice.
iPLA2␥ Deletion Enhances Podocyte Ultrastructural Abnormalities in Anti-GBM Nephritis—After injection of anti-GBM
antibody, glomerular and tubular morphology of WT and
iPLA2␥ KO mice (n ⫽ 6 –7 mice) appeared normal by light
microscopy; in particular, there was no inflammatory cell infiltration in the glomeruli (results not shown). Kidneys of albuminuric (anti-GBM antibody-treated) and control mice (salinetreated groups) were also examined by electron microscopy.
The 3-month-old saline-treated KO mice showed no apparent
glomerular abnormalities, and podocyte ultrastructure
appeared normal (Fig. 8A). Similarly, the saline-treated WT
mice showed no ultrastructural abnormalities (result not
shown). Anti-GBM-injected WT mice showed focal abnormalities in podocyte ultrastructure (Fig. 8B). Some podocyte cell
bodies appeared swollen, and there was some villous transformation and microvesiculation of the podocyte plasma membranes. In most areas of the glomerulus, foot processes
appeared normal, but in other areas, there were abnormalities,
ranging from short and widened foot processes to patchy
effacement (Fig. 8B). Anti-GBM-injected iPLA2␥ KO mice
showed substantially more severe abnormalities in podocyte
ultrastructure. Podocyte cell bodies were swollen with fewer
organelles, and there was extensive villous transformation and
microvesiculation of the plasma membranes. Foot processes
were severely malformed and were effaced extensively (Fig. 8C).
However, there were no apparent abnormalities in the ultrastructure of organelles, including mitochondria, and no apparent autophagosomes. There was an absence of leukocytes in the
glomeruli. To quantify podocyte foot process effacement objectively, we measured foot process width in iPLA2␥ KO and WT
mice in both saline- and anti-GBM-injected groups. The antiGBM-injected iPLA2␥ KO mice showed the greatest foot process width, indicating severe foot process effacement (Fig. 8D).
Taken together, deletion of iPLA2␥ in anti-GBM nephritis
induced severe abnormalities in podocyte ultrastructure, which
are in keeping with the increased level of albuminuria in these
mice.
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iPLA2␥ Deletion Induces Marked Podocyte Loss in Anti-GBM
Nephritis—In addition to albuminuria, glomerular injury may
be associated with loss of podocytes. To provide further evidence for a cytoprotective effect of iPLA2␥ in vivo, we quantified the number of podocyte nuclei in glomeruli of KO and WT
mice by WT1 immunostaining. In saline-treated mice (age 3
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FIGURE 7. iPLA2␥ deletion exacerbates albuminuria in anti-GBM nephritis. Nephritis was induced in WT and iPLA2␥ KO mice (3– 4 months of age) via
single intravenous injection of sheep anti-rat GBM antiserum (aGBM). Control
mice received saline. The urinary albumin/creatinine ratio was measured
before and 24 h after the injection. A, after the induction of anti-GBM nephritis, iPLA2␥ KO mice had greater albuminuria compared with WT. *, p ⬍ 0.05,
iPLA2␥ KO anti-GBM versus WT anti-GBM. KO anti-GBM, n ⫽ 7 mice (4 females
and 3 males); WT anti-GBM, n ⫽ 7 mice (2 females and 5 males); KO control,
n ⫽ 4 mice; WT control, n ⫽ 4 mice. B, immunofluorescence staining for sheep
(Sh) anti-GBM IgG and mouse complement C3 in mice with anti-GBM nephritis (at 24 h). There is bright glomerular fluorescence staining for sheep IgG in
both WT and iPLA2␥ KO mice. Fainter glomerular C3 staining was present in
both groups of mice. The C3 staining of Bowman’s capsule (surrounding the
glomerulus) is observed in normal mouse kidneys and is not due to the
administration of anti-GBM antibody. Bar, 20 m. C, quantification of antiGBM antibody and complement C3 deposition (fluorescence intensity) in
arbitrary units shows no significance differences between groups. Error bars,
S.E.

months), deletion of iPLA2␥ did not alter the number of WT1positive cells compared with WT. Furthermore, in WT mice,
injection of anti-GBM antiserum did not alter the number of
WT1-positive cells. In contrast, there was a ⬃60% decrease in
the number of WT1-positive cells in iPLA2␥ KO glomeruli after
anti-GBM antiserum injection (Fig. 9, A and B). Therefore,
genetic ablation of iPLA2␥ induced a marked loss of podocytes
after these cells were subjected to injury. Taken together, the
results indicate that iPLA2␥ exerts a cytoprotective effect on the
podocyte and glomerular injury in vivo.
Effects of iPLA2␥ Deletion on Expression of Nephrin and ER
Stress Proteins in Anti-GBM Nephritis—The expression of
nephrin was examined by immunofluorescence microscopy
and was then quantified. In parallel with albuminuria, antiGBM antibody induced a decrease in nephrin expression in
both WT and iPLA2␥ KO mice; nephrin expression tended to
be lower in iPLA2␥ KO mice, compared with WT, but the difference did not reach statistical significance (Fig. 9, A and C). By
immunoblotting, expression of the mature form of nephrin was
reduced markedly in anti-GBM nephritis but comparably in
WT and iPLA2␥ KO mice (Fig. 10, A (top nephrin band) and B).
Furthermore, the amount of mature nephrin (top band) was
reduced significantly relative to the ER form (bottom band) in
anti-GBM nephritic mice (Fig. 10, A and C). These results imply
that in anti-GBM nephritis, there is defective glycosylation of
nephrin due to ER dysfunction, although this appears to be
largely independent of iPLA2␥.
To further address the role of iPLA2␥ in ER function in vivo,
we monitored the unfolded protein response (i.e. changes in the
expression of ER chaperones after induction of anti-GBM
nephritis). Glomerular GRP94 and GRP78 (BiP) were up-regulated significantly in the KO anti-GBM mice but not in WT (Fig.
10, A, D, and E). There were no consistent changes in CHOP
(CCAAT/enhancer-binding protein homologous protein)
among groups (results not shown). These results imply that
deletion of iPLA2␥ in the context of glomerulonephritis leads to
amplification of the adaptive unfolded protein response. The
dose of anti-GBM antibody used in this study was low, allowing
us to ascertain differences in albuminuria between iPLA2␥ and
WT mice. At substantially higher doses of antibody, WT mice
with anti-GBM nephritis also show comparable increases in
glomerular expression of GRP94 and BiP (results not shown).
However, at these higher doses, albuminuria is massive and
does not allow for the study of iPLA2␥ effects.
Mitochondrial Injury Enhances Complement-mediated
Cytotoxicity—The primary pathological finding in aging
iPLA2␥ KO mice is mitochondrial damage in podocytes (Fig. 2).
Compared with WT, iPLA2␥ KO mice (age 3 months) showed
greater albuminuria and podocyte injury after induction of
anti-GBM nephritis (Figs. 7A and 8), but mitochondrial ultrastructural damage in the podocytes was not observed. Nevertheless, to determine whether enhanced complement-mediated podocyte injury in anti-GBM nephritis in the iPLA2␥ KO
mice may have been associated with underlying mitochondrial
dysfunction, we examined the role of the mitochondria in
complement-dependent cytolysis in cultured GECs. We pretreated GECs with antimycin A to impair mitochondrial function. Then both untreated and antimycin A-treated GECs were
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incubated with antibody and complement, and cytotoxicity was
monitored by release of LDH. As expected, complement-mediated cytolysis increased with serially increasing doses of complement, and pretreatment of cells with antimycin A enhanced
complement-mediated cytolysis at every dose (Fig. 11). For
comparison, in analogous experiments, GECs were pretreated
with tunicamycin, which induces cytotoxic ER stress (21).
Tunicamycin did not, however, enhance complement cytotolysis (data not shown). These results indicate that mitochondrial
dysfunction in cultured GECs enhances complement-mediated
cytotoxicity and support the view that exacerbation of GEC
injury in anti-GBM nephritis in the iPLA2␥ KO mice was associated with underlying mitochondrial dysfunction.
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with anti-GBM antibody. Podocyte cell bodies appear swollen, and the cell
membranes show marked villous transformation and microvesiculation.
Podocyte foot processes are almost completely effaced. D, quantification of
foot process width in iPLA2␥-KO and WT mice. *, p ⬍ 0.0001 KO/anti-GBM
versus other groups, 9 –36 measurements/group. Error bars, S.E.
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FIGURE 8. iPLA2␥ deletion exacerbates abnormalities in podocyte ultrastructure in anti-GBM nephritis. Kidneys of four albuminuric mice (two
iPLA2␥ KO and two WT; 3–5 glomeruli/mouse) and three control mice (salinetreated groups) were examined by electron microscopy. A, an iPLA2␥ KO
mouse (age 3 months) injected with saline shows normal podocyte ultrastructure. Foot processes, cell bodies, and intracellular organelles appear
intact (bar, 500 nm). B, WT mouse (age 3 months) injected with anti-GBM
antibody. In this electron micrograph, podocyte foot processes appear widened with segmental effacement. There is some villous transformation of the
podocyte plasma membranes. C, iPLA2␥ KO mouse (age 3 months) injected

Discussion
In this study, we demonstrated that deletion of iPLA2␥
resulted in striking mitochondrial abnormalities in GECs/
podocytes of 10 –11-month-old mice (Fig. 2). These ultrastructural abnormalities were widespread and included disruption of
membranes, loss of cristae, fission, and aggregation (Fig. 2).
Aging iPLA2␥ KO mice also demonstrated podocyte plasma
membrane damage and slight but significant widening of foot
processes compared with WT (Fig. 2). Expression of synaptopodin was lower in iPLA2␥ KO glomeruli (Figs. 3 and 4), and
there was a ⬃25% decrease in the number of WT1-positive cells
in iPLA2␥ KO glomeruli compared with control (Fig. 3), implying that deletion of iPLA2␥ induced a loss of podocytes. In association with mitochondrial damage, phosphorylation of AMPK
was increased in iPLA2␥ KO glomeruli (Fig. 4), consistent with
reduced ATP generation by mitochondria in KO podocytes
leading to podocyte injury. In the aging iPLA2␥ KO mice, some
podocytes contained prominent autophagic vacuoles (Fig. 2).
There was also an increase in the glomerular ratio of LC3-II/
LC3-I protein expression in KO mice, in keeping with accumulation of autophagic vacuoles (Fig. 4). Surprisingly, the ultrastructural abnormalities in aging podocytes were not associated
with development of albuminuria (Fig. 1) or renal failure,
although these could potentially appear at a more advanced age.
Studies in cultured GECs derived from WT and iPLA2␥ KO
mice showed that deletion of iPLA2␥ impaired mitochondrial
function and enhanced autophagy (Figs. 5 and 6). Indeed, the
clustering of mitochondria in the perinuclear regions of cells (as
observed in iPLA2␥ KO GECs) is reported to be associated with
autophagy (36). Thus, the GEC culture studies recapitulate the
phenotype in vivo and support the functional importance of the
ultrastructural findings and low cell energy stores in iPLA2␥
KO glomeruli.
In cells, iPLA2␥ is localized at the mitochondria, ER, and
peroxisomes (3). There are several variants of iPLA2␥, and subcellular localization may, at least in part, depend on the variant
expressed in the specific cell type (3, 20, 37). Previously, we
demonstrated that iPLA2␥ mRNA and protein of 88 kDa are
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expressed in the glomerulus in vivo (19). GFP-tagged iPLA2␥
was localized at the ER and mitochondria in cultured GECs, and
this pattern of localization was dependent on the N-terminal
domain of iPLA2␥ (20). Our results in podocytes are in keeping
with previous studies, where deletion of iPLA2␥ in mice
resulted in mitochondrial disruption. For example, deletion of
iPLA2␥ induced mitochondrial dysfunction in the heart, skeletal muscle, liver, and brain (7, 8, 10, 11). iPLA2␥ KO mice displayed cold intolerance, a defect in mitochondrial cytochrome
oxidase, and multiple bioenergetic dysfunctional phenotypes at
4 – 6 months of age (7). In skeletal muscle of 4-month-old KO
mice, there was mitochondrial dysfunction, oxidative stress,
and lipid peroxidation (11). These mice exhibited growth retardation. iPLA2␥ deletion induced significant changes in mitochondrial phospholipid homeostasis (see below). In aging mice
(10 months), this was associated with ultrastructural evidence
for enlarged and degenerating mitochondria in the brain,
autophagy, and cognitive dysfunction (8). These studies identified an obligatory role for iPLA2␥ in mitochondrial structure.
Increased autophagy in podocytes of 10 –11-month-old
iPLA2␥ KO mice (Fig. 2) may have been triggered by reduced
ATP levels and activation of AMPK (Fig. 4). Actually, AMPK
has been implicated as an important positive regulator of
autophagy (30, 31). Autophagy was less likely to have been due
to ER stress, since there was no evidence for significant ER
dysfunction in iPLA2␥ KO mice (Fig. 4). It has been suggested
that in podocytes, reduced ubiquitin-proteasome function
JULY 8, 2016 • VOLUME 291 • NUMBER 28

might result in increased autophagy (30, 38). We did not, however, observe any differences in polyubiquitination of glomerular proteins between iPLA2␥ KO and WT mice (result not
shown). Determination of whether cross-talk between these
two systems plays a mechanistic role in injury will require further study. In iPLA2␥ KO podocytes, autophagy may promote
survival by improving cell energy levels. Enhanced autophagy in
podocytes as well as in the brains of iPLA2␥ KO mice may also
be a cytoprotective mechanism to clear damaged mitochondria
from the cytoplasm (30, 31, 38). Based on a study in Atg5 KO
mice, autophagy appears to be a homeostatic mechanism to
maintain podocyte integrity and a protective mechanism
against aging and glomerular injury (30).
It should be noted that in contrast to podocytes, mitochondria in other kidney cell types, including parietal epithelial cells
and proximal tubular epithelial cells in iPLA2␥ KO mice,
showed normal ultrastructure (Fig. 2). This finding in proximal
tubular epithelial cells was unexpected because the function of
these cells is highly dependent on mitochondrial energy production, and depletion of iPLA2␥ in cultured proximal tubular
epithelial cells in previous studies resulted in metabolic abnormalities (see below) (22). In contrast to podocytes, which
appear to contain relatively few, small mitochondria, tubular
cells in vivo contain numerous, large mitochondria (Fig. 2). Perhaps a more robust mitochondrial structure allowed the tubular cells to withstand potential damage from the deletion of
iPLA2␥ in vivo. Alternatively, there may be differences in
JOURNAL OF BIOLOGICAL CHEMISTRY

14479

Downloaded from http://www.jbc.org/ at Washington University on January 17, 2017

FIGURE 9. Immunofluorescence staining for WT1 and nephrin in anti-GBM nephritis. A and B, iPLA2␥ deletion reduced podocyte number in anti-GBM
nephritis. WT1 immunofluorescence was assessed in two WT mice without and with anti-GBM antibody and four iPLA2␥ KO mice (age 3– 4 months), without
and with anti-GBM antibody. Bar, 20 m. B, quantification of WT1-positive nuclei per glomerulus (25–36 glomeruli/group). *, p ⬍ 0.001 KO/anti-GBM versus
WT/anti-GBM. A and C, nephrin immunofluorescence intensity was assessed in iPLA2␥ KO mice without (n ⫽ 2) and with anti-GBM antibody (n ⫽ 6) and in WT
mice without (n ⫽ 2) and with anti-GBM antibody (n ⫽ 5). *, p ⬍ 0.0001 anti-GBM versus saline (14 –31 measurements/group). Error bars, S.E.
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FIGURE 11. Mitochondrial injury enhances complement-mediated cytotoxicity. Cultured GECs were preincubated with or without antimycin A (10
M, 30 min). Then untreated and antimycin A-treated GECs were incubated
with anti-GEC antibody (40 min) and complement (5, 10, and 15% normal
serum; heat-inactivated serum in controls) for 40 min. Cytolysis was monitored by release of LDH. *, p ⬍ 0.001 antimycin A versus untreated (four experiments). Antimycin A had no significant independent effect on cytolysis. Error
bars, S.E.

iPLA2␥ variants, expression, or activation among the renal cell
types. Finally, certain cells may activate alternate mechanisms
to compensate for iPLA2␥ deficiency, or the podocyte, a cell
with limited proliferative capacity (12, 14), may not be able to
withstand mitochondrial damage, unlike proximal tubular
cells, which have high potential for proliferation and repair
from injury (39).
In regard to its role in lipid homeostasis, deletion of iPLA2␥
resulted in a decrease in cardiolipin content and altered cardiolipin molecular species distribution in heart and skeletal muscle mitochondria, but there were no significant changes in
phospholipids and triglycerides (7, 9, 11). In brain hippocampal
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FIGURE 10. Effect of iPLA2␥ on the expression of nephrin and ER stress
proteins in anti-GBM nephritis. Glomeruli were isolated from 3-month-old
WT and iPLA2␥ KO mice that were treated with anti-GBM antibody or saline (at
24 h). Lysates were immunoblotted as indicated. A, representative immunoblots. The white lines indicate reassembly of noncontiguous gel lanes. There
were no adjustments made to the digital images among the lanes that would
alter the information in the panels. B–E, densitometric quantification. B and C,
anti-GBM antibody reduced expression of mature nephrin (top nephrin band)
as well as maturation of nephrin (ratio of top to bottom band) in both WT and
iPLA2␥ KO mice. B, *, p ⬍ 0.02; **, p ⬍ 0.01, anti-GBM versus saline (3– 4 mice/
group). C, *, p ⫽ 0.05; **, p ⬍ 0.02 anti-GBM versus saline (3– 4 mice/group). D
and E, anti-GBM antibody increased expression of GRP94 and BiP (GRP78) in
iPLA2␥ KO mice. D, *, p ⬍ 0.005 KO/anti-GBM versus KO/saline (3– 4 mice/
group). E, *, p ⬍ 0.02, KO/anti-GBM versus KO/saline (3– 4 mice/group). Error
bars, S.E.

lipid extracts, iPLA2␥ KO mice showed an increase in various
cardiolipin molecular species, increases in arachidonoyl-phosphatidylcholine and oxidized phosphatidylethanolamine, an
increase in ceramide, and a decrease in plasmalogen-phosphatidylethanolamine (8). Decreased iPLA2␥ expression in
cultured renal proximal tubular cells mildly enhanced phosphatidylcholine and phosphatidylethanolamine levels (22).
Cardiolipin is an important mitochondrial lipid, and proper
remodeling of cardiolipin is essential for efficient electron
transport chain function. Defects in cardiolipin have also been
associated with aging. Thus, abnormal cardiolipin remodeling
in iPLA2␥-deficient cells would be expected to result in defective electron coupling and bioenergetic inefficiency (8). It
should be noted that although distinct directional changes in
cardiolipin levels were observed in the heart and brain, mitochondrial function was impaired in both instances. Furthermore, disruption of iPLA2␥-mediated release of fatty acids may
impair important signaling that is required for mitochondrial
function (9).
The podocyte plays a key role in maintaining glomerular
permselectivity. In normal podocytes, actin filaments are the
core structural components of foot processes. Studies predominantly in cell culture models suggest that podocytes require a
high energy supply to maintain various cellular functions,
including the organization of cytoskeletal and GBM proteins
(40). Condensation of the actin cytoskeleton at the base of
effaced podocyte foot processes, together with alterations in
filtration slits and displacement and disruption of slit diaphragms, are features of established proteinuric glomerular diseases (12–14, 17). As noted above, podocyte injury was
observed in aging iPLA2␥ KO mice (Fig. 2), but this was not
associated with albuminuria (Fig. 1). Possibly, there was sufficient mitochondrial reserve, and the podocytes were able to
maintain their permselective function. Despite the ⬃25% loss
of podocytes, the remaining podocytes may have been able to
stretch and/or hypertrophy to compensate for the decreased
number. Actually, the loss of podocytes may have been below
the threshold required to produce extensive GBM denudation,
proteinuria, and sclerotic lesions (16, 41, 42). In another mouse
model of mitochondrial dysfunction, due to deletion of the
Mpv17 gene, which is expressed in podocytes, albuminuria and
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unfolded protein response, particularly activation of the ATF6
pathway (38, 46, 47). This result is apparently discrepant from
an earlier study, where it was demonstrated that overexpression
of iPLA2␥ enhanced ATF6 activation, whereas deletion
reduced activation in cultured GECs (21). The reason for this
discrepancy will require further elucidation; however, it is likely
that multiple signaling pathways are activated by complement
in the in vivo anti-GBM nephritis model (18), and a number of
these could potentially impact the unfolded protein response.
Activation of the adaptive unfolded response in anti-GBM
nephritis is similar to experimental membranous nephropathy,
a glomerular disease mediated by complement C5b-9 (17, 38,
46).
In conclusion, the results of this study demonstrate an
important role for iPLA2␥ in maintaining podocyte integrity
both in the normal kidney and in glomerular disease. In the
future, modulation of iPLA2␥ enzymatic activity may potentially represent a novel approach to limiting GEC injury and
proteinuria.
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Induction of podocyte injury with anti-GBM antibody
revealed a protective phenotype of iPLA2␥ in young mice. In
heterologous anti-GBM nephritis, activation of complement
and assembly of C5b-9 induces podocyte “stress” (24, 34, 35).
iPLA2␥ KO mice with anti-GBM nephritis had increased albuminuria and a remarkable reduction in podocytes compared
with WT mice (Figs. 7 and 9; see below). Moreover, iPLA2␥ KO
mice showed substantially more severe abnormalities in podocyte ultrastructure, including swelling of cell bodies, marked
villous transformation, and microvesiculation of plasma membranes, and almost complete foot process effacement (Fig. 8).
Although structural abnormalities in podocyte organelles were
not evident, studies in cultured GECs demonstrated that mitochondrial dysfunction can enhance complement-mediated
cytotoxicity (Fig. 11), implying that podocyte injury in antiGBM nephritis in iPLA2␥ KO mice was most likely exacerbated
due to underlying mitochondrial dysfunction. The association
of podocyte mitochondrial dysfunction with proteinuria has
been reported (40). By analogy to our study, after induction of
anti-GBM nephritis in mice with mitochondrial dysfunction
(Mpv17 gene deletion), the KO mice had greater levels of albuminuria compared with control, although the anti-GBM model
employed in this study was more chronic (4 days) (43). We
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results, it is reasonable to conclude that iPLA2␥ is cytoprotective. This in vivo result is consistent with earlier studies, which
showed that increased expression of iPLA2␥ in cultured GECs
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As noted above, deletion of iPLA2␥ resulted in a decrease in
podocyte number in aging mice (Fig. 2) and a more marked
decrease in podocytes in younger mice with anti-GBM nephritis (Fig. 9). There is both experimental and clinical evidence to
support the view that podocyte apoptosis leads to glomerular
disease and proteinuria (14, 16, 41, 42). The presence of iPLA2␥
at the mitochondria may therefore provide an anti-apoptotic
effect in the aging kidney and in anti-GBM nephritis. A second
possibility is that loss of podocytes is due to podocyte detachment from the GBM and the subsequent appearance of viable
cells in the urine (44, 45). iPLA2␥ deletion potentially impairs
the energy required for the production or function of proteins
involved in mediating podocyte foot process adhesion to the
GBM. Additional proof of these mechanisms will require further study.
Although we previously showed that the presence of iPLA2␥
at the ER is functionally important in terms of ER signaling in
cultured GECs (21), deletion of iPLA2␥ in aging mice did not
lead to any apparent abnormalities in ER morphology or function (Figs. 2– 4). However, glomerular expression of the ER
chaperones, BiP and GRP94, was increased in iPLA2␥ KO mice
with anti-GBM nephritis (Fig. 10), implying that deletion of
iPLA2␥ in the context of nephritis enhanced the adaptive
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28. Bechtel, W., Helmstädter, M., Balica, J., Hartleben, B., Kiefer, B., Hrnjic, F.,

Genetic Ablation of Calcium-independent Phospholipase A2γ Induces Glomerular
Injury in Mice
Hanan Elimam, Joan Papillon, Daniel R. Kaufman, Julie Guillemette, Lamine Aoudjit,
Richard W. Gross, Tomoko Takano and Andrey V. Cybulsky
J. Biol. Chem. 2016, 291:14468-14482.
doi: 10.1074/jbc.M115.696781 originally published online May 12, 2016

Access the most updated version of this article at doi: 10.1074/jbc.M115.696781

Click here to choose from all of JBC's e-mail alerts
This article cites 47 references, 22 of which can be accessed free at
http://www.jbc.org/content/291/28/14468.full.html#ref-list-1

Downloaded from http://www.jbc.org/ at Washington University on January 17, 2017

Alerts:
• When this article is cited
• When a correction for this article is posted

